Digital counseling for chronic kidney disease self-care and education
Official title: Open Access Digital CommunitY Promoting Self-Care, Peer Support, and HEalth LitEracy (ODYSSEE) for Kidney Health (KH) Trial
Run by University Health Network, Toronto · NCT06274710 · Data updated 2026-11-12
This study is testing a digital counseling program to see if it can help people with severe chronic kidney disease take better care of themselves and choose home dialysis options compared to regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 344 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | December 13, 2023 |
| Main results expected | April 13, 2026 |
| Study ends | April 13, 2026 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT06274710 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with a greater than 10% risk of requiring dialysis within 2 years and who are registered in a nephrology clinic.
✕Probably not a fit
Patients who have previously undergone a kidney transplant or have severe co-morbidities that limit their participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The ODYSSEE Kidney Health Trial aims to improve self-care behaviors and education regarding renal replacement therapy (RRT) for patients with severe chronic kidney disease (CKD) through a digital counseling intervention. This approach utilizes cognitive behavioral therapy and motivational interviewing techniques to enhance patient engagement and decision-making regarding home dialysis options. The trial will compare the effectiveness of this digital intervention against usual care in increasing the incidence of home RRT over a median follow-up period of 19 months. The study also seeks to assess improvements in hospitalization rates and overall quality of life for participants.
Why it matters
Potential benefit: If successful, this trial could significantly enhance the quality of life and treatment options for patients with severe CKD by promoting home dialysis.
How similar studies have gone: Previous studies have shown that educational interventions for CKD patients can lead to improved outcomes, suggesting potential success for this digital approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * CKD patients who are at least 18 years old, that have a greater than a 10% risk of requiring dialysis within 2 years, using the 4-variable 2-year Kidney Failure Risk Equation,1,2 and are registered in a nephrology clinic (including an in-center dialysis clinic) at a participating hospital * Confirmation from a referring nephrologist that the CKD has been stable for at least 1 month at the time of enrollment * Oral and written comprehension of English or French * Informed written consent * At least a basic level of self-reported computer literacy * Access to the internet and a computer Exclusion Criteria: * Previous kidney transplant or waitlisted for organ transplant at the time of enrollment * Severe co-morbidities that prohibit full participation (e.g., dementia, clinically severe depression) * Diagnosis of a medical condition for which the life expectancy is less than 2 years.
Where it's running
-
University Health Network
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Robert Nolan, PhD — University Health Network, Toronto
- Study coordinator: Robert Nolan, PhD
- Email: rob.nolan@uhn.ca
- Phone: (416) 340-4800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Oral Semaglutide for CKD and MAFLD in adults with diabetes
This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.
-
Eye-brain-kidney connections in chronic kidney disease
This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.
-
Screening for chronic kidney disease
We will see how common chronic kidney disease is among adults followed at a tertiary care center and how many cases were previously undiagnosed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.